Index | MSCI UK |
Investment focus | Equity, United Kingdom |
Fund size | GBP 91 m |
Total expense ratio | 0.33% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | GBP |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 9.69% |
Inception/ Listing Date | 12 January 2010 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
Revision Company | Deloitte |
Fiscal Year End | 31 July |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
AstraZeneca PLC | 8.41% |
Shell Plc | 8.06% |
HSBC Holdings Plc | 6.84% |
Unilever Plc | 6.03% |
RELX | 3.53% |
BP Plc | 3.20% |
British American Tobacco plc | 3.04% |
GSK Plc | 2.84% |
Rio Tinto Plc | 2.83% |
London Stock Exch Grp | 2.73% |
United Kingdom | 92.33% |
Switzerland | 2.30% |
Ireland | 2.06% |
Other | 3.31% |
Financials | 19.35% |
Consumer Staples | 18.54% |
Industrials | 13.49% |
Health Care | 11.86% |
Other | 36.76% |
YTD | +4.03% |
1 month | +5.23% |
3 months | +2.09% |
6 months | +5.56% |
1 year | +17.46% |
3 years | +25.65% |
5 years | +31.72% |
Since inception (MAX) | +153.57% |
2024 | +9.01% |
2023 | +7.24% |
2022 | +6.74% |
2021 | +19.16% |
Volatility 1 year | 9.69% |
Volatility 3 years | 12.61% |
Volatility 5 years | 17.13% |
Return per risk 1 year | 1.80 |
Return per risk 3 years | 0.63 |
Return per risk 5 years | 0.33 |
Maximum drawdown 1 year | -4.74% |
Maximum drawdown 3 years | -9.08% |
Maximum drawdown 5 years | -34.11% |
Maximum drawdown since inception | -34.32% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
London Stock Exchange | GBX | CSUK | - - | - - | - |
gettex | EUR | SXR3 | - - | - - | - |
Stuttgart Stock Exchange | EUR | SXR3 | - - | - - | - |
Bolsa Mexicana de Valores | MXN | - | CSUKN MM | CSUKN.MX | |
Borsa Italiana | EUR | CSUK | CSUK IM IXM0411 | CSUK.MI IXM0411.DE | |
SIX Swiss Exchange | GBP | CSUK | CSUK SE IXM041 | CSUK.S IXM041.DE | |
XETRA | EUR | SXR3 | SXR3 GY IXM0411 | SXR3.DE IXM0411.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
UBS ETF (LU) MSCI UK UCITS ETF (GBP) A-acc | 1,573 | 0.20% p.a. | Accumulating | Full replication |
UBS ETF (LU) MSCI UK UCITS ETF (GBP) A-dis | 55 | 0.20% p.a. | Distributing | Full replication |